Siemens' DPC (Diagnostic Products Corporation) buy gets German OK:
This article was originally published in Clinica
Executive Summary
Siemens' proposed acquisition of Los Angeles, California-based immunodiagnostics company Diagnostic Products Corporation (DPC) has received clearance from German antitrust authorities. The news comes shy of a week after the US Federal Trade Commission gave the go-ahead to the $1.86bn transaction (see Clinica No 1211, p 14). The companies still require shareholder approval before closing the acquisition.